Annual report pursuant to Section 13 and 15(d)

Condensed Consolidated Statements Of Changes in Stockholders' Equity (Deficit)

v3.23.1
Condensed Consolidated Statements Of Changes in Stockholders' Equity (Deficit) - USD ($)
$ in Thousands
Total
Common Stock warrants
Merger
Common Stock warrants
Sponsor Shares
Promissory Notes
Common Stock
Common Stock
Common Stock warrants
Common Stock
Merger
Common Stock warrants
Common Stock
Sponsor Shares
Common Stock
Promissory Notes
Additional Paid-in Capital
Additional Paid-in Capital
Common Stock warrants
Additional Paid-in Capital
Merger
Common Stock warrants
Additional Paid-in Capital
Sponsor Shares
Additional Paid-in Capital
Promissory Notes
Accumulated Deficit
Balance at beginning of period at Dec. 31, 2020 $ (32,813)         $ 3         $ 191,168         $ (223,984)
Balance at beginning of period (in shares) at Dec. 31, 2020           34,692,000                    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                
Stock-based compensation 42,582                   42,582          
Issuance of common stock due to Bridge Notes 106,353         $ 2         106,351          
Issuance of common stock due to Bridge Notes (in shares)           20,343,000                    
Issuance of common stock upon exercise of stock options (in shares)           1,044,000                    
Issuance of common stock upon exercise of stock options 130                   130          
Issuance of common stock upon vesting of restricted stock awards (in shares)           546,000                    
Issuance of common stock upon vesting of restricted stock units (in shares)           111,000                    
Issuance of common stock on conversion (in shares)   2,289,000         3,251,000 11,187,000 7,736,000 958,000   2,289,000        
Issuance of common stock on conversion     $ 38,329 $ 77,097       $ 1 $ 1       $ 38,328 $ 77,096    
Issuance of Sponsor Shares (17,659)                   (17,659)          
Reverse recapitalization, net (in shares)           34,584,000                    
Reverse recapitalization, net 200,917         $ 4         202,195         (1,282)
Repurchase and retirement of common stock 0                              
Stock Issued During Period, Value, Conversion of Convertible Securities, Net of Adjustments         $ 8,038                   $ 8,038  
Other comprehensive income (loss) 0                              
Net loss (245,643)                             (245,643)
Balance at end of period at Dec. 31, 2021 $ 179,620         $ 11         650,518         (470,909)
Balance at end of period (in shares) at Dec. 31, 2021 114,452,000         114,452,000                    
Balance at beginning of period (in shares) at Sep. 08, 2021 31,625,000                              
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                
Reverse recapitalization, net (in shares) 34,584,000                              
Balance at beginning of period (in shares) at Dec. 31, 2021 114,452,000         114,452,000                    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                
Stock-based compensation $ 21,477                   21,477          
Issuance of common stock upon exercise of stock options (in shares) 709,000         709,000                    
Issuance of common stock upon exercise of stock options $ 47                   47          
Issuance of common stock upon vesting of restricted stock awards (in shares)           200,000                    
Issuance of common stock upon vesting of restricted stock units (in shares)           6,728,000                    
Issuance of common stock upon vesting of restricted stock units 1         $ 1                    
Withholding of restricted stock to satisfy tax withholding obligations upon the vesting of the related restricted stock (in shares)           2,566,000                    
Withholding of restricted stock units to satisfy tax withholding obligations upon the vesting of restricted stock units $ (5,069)                   (5,069)          
Repurchase and retirement of common stock (in shares) (14,603)         (15,000)                    
Repurchase and retirement of common stock $ (30)                             (30)
Other comprehensive income (loss) 0                              
Net loss (74,172)                             (74,172)
Balance at end of period at Dec. 31, 2022 $ 121,874         $ 12         $ 666,973         $ (545,111)
Balance at end of period (in shares) at Dec. 31, 2022 119,508,000         119,508,000